TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from China Bozza Development Holdings Limited ( (HK:1069) ).
China Health Technology Group Holding Company Limited has announced a board meeting scheduled for September 30, 2025, to discuss and approve the annual results for the year ending June 30, 2025, and to consider the payment of a final dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential returns to shareholders, which could impact its market positioning and stakeholder interests.
The most recent analyst rating on (HK:1069) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on China Bozza Development Holdings Limited stock, see the HK:1069 Stock Forecast page.
More about China Bozza Development Holdings Limited
China Health Technology Group Holding Company Limited operates in the health technology industry, focusing on providing innovative health solutions and services. The company is involved in various health-related technologies and services, aiming to enhance healthcare delivery and outcomes.
Average Trading Volume: 949,409
Technical Sentiment Signal: Sell
Current Market Cap: HK$42.2M
Learn more about 1069 stock on TipRanks’ Stock Analysis page.